ACTQRX ADT 1913 Advisors Corporate Trust - Navellier / Dial High Income Opportunities Portfolio Series 132

USD 654.40 -0.05 ( -0.01)%
Icon

ADT 1913 Advisors Corporate Trust - Navellier / Dial High Income Opportunities Portfolio Series 132 (ACTQRX) Stock Analysis and Price Targets

FUND | Others | NMF
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 654.40

-0.05 (-0.01)%

N/A

N/A

USD 0.00

N/A

Icon

ACTQRX

ADT 1913 Advisors Corporate Trust - Navellier / Dial High Income Opportunities Portfolio Series 132 (USD)
FUND | NMF
USD 654.40
-0.05 ( -0.01)%

ADT 1913 Advisors Corporate Trust - Navellier / Dial High Income Opportunities Portfolio Series 132 (ACTQRX) Stock Forecast

N/A

Based on the ADT 1913 Advisors Corporate Trust - Navellier / Dial High Income Opportunities Portfolio Series 132 stock forecast from 0 analysts, the average analyst target price for ADT 1913 Advisors Corporate Trust - Navellier / Dial High Income Opportunities Portfolio Series 132 is not available over the next 12 months. ADT 1913 Advisors Corporate Trust - Navellier / Dial High Income Opportunities Portfolio Series 132’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ADT 1913 Advisors Corporate Trust - Navellier / Dial High Income Opportunities Portfolio Series 132 is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, ADT 1913 Advisors Corporate Trust - Navellier / Dial High Income Opportunities Portfolio Series 132’s stock price was USD 654.40. ADT 1913 Advisors Corporate Trust - Navellier / Dial High Income Opportunities Portfolio Series 132’s stock price has changed by -0.05% over the past week, -0.03% over the past month and -17.99% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...